Rittenhouse Oncology And Hemotology Inc is categorized under Doctors in Philadelphia, PA and active since 1999.
Rittenhouse Oncology And Hemotology Inc was established in 1999, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Rene Rubin at the company’s single location by writing to 1840 South St # 4, Philadelphia, Pennsylvania PA 19146 or by phoning (215) 893-5900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rittenhouse Oncology And Hemotology Inc |
| Contact Person: | Rene Rubin |
| Address: | 1840 South St # 4, Philadelphia, Pennsylvania 19146 |
| Phone Number: | (215) 893-5900 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Rittenhouse Oncology And Hemotology Inc was started in 1999 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Rene Rubin for inquiries that concern Rittenhouse Oncology And Hemotology Inc by calling the company number (215) 893-5900, as your correspondence is most welcome. Additionally, the physical location of the single location of Rittenhouse Oncology And Hemotology Inc can be found at the coordinates 39.944477,-75.173231 as well as the street address 1840 South St # 4 in Philadelphia, Pennsylvania 19146.
For its online presence, you may visit Rittenhouse Oncology And Hemotology Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.